These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15560849)

  • 61. Role of Smac/DIABLO in cancer progression.
    Martinez-Ruiz G; Maldonado V; Ceballos-Cancino G; Grajeda JP; Melendez-Zajgla J
    J Exp Clin Cancer Res; 2008 Sep; 27(1):48. PubMed ID: 18822137
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Role of mitochondrial protein Smac/Diablo in regulation of apoptotic pathways].
    Korga A; Korobowicz E; Dudka J
    Pol Merkur Lekarski; 2006 May; 20(119):573-6. PubMed ID: 16875166
    [TBL] [Abstract][Full Text] [Related]  

  • 63. SMAC is expressed de novo in a subset of cervical cancer tumors.
    Espinosa M; Cantu D; Lopez CM; De la Garza JG; Maldonado VA; Melendez-Zajgla J
    BMC Cancer; 2004 Nov; 4():84. PubMed ID: 15560849
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance.
    Mizutani Y; Nakanishi H; Yamamoto K; Li YN; Matsubara H; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    J Clin Oncol; 2005 Jan; 23(3):448-54. PubMed ID: 15572731
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of Smac gene over-expression on the radiotherapeutic sensitivities of cervical cancer cell line HeLa.
    Zheng LD; Xiong ZF; Zhu JW; Wang ZH
    Chin Med J (Engl); 2005 Feb; 118(3):226-30. PubMed ID: 15740652
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High Smac/DIABLO expression is associated with early local recurrence of cervical cancer.
    Arellano-Llamas A; Garcia FJ; Perez D; Cantu D; Espinosa M; De la Garza JG; Maldonado V; Melendez-Zajgla J
    BMC Cancer; 2006 Oct; 6():256. PubMed ID: 17067390
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical significance of Smac/DIABLO expression in colorectal cancer.
    Endo K; Kohnoe S; Watanabe A; Tashiro H; Sakata H; Morita M; Kakeji Y; Maehara Y
    Oncol Rep; 2009 Feb; 21(2):351-5. PubMed ID: 19148507
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibitors of apoptosis proteins in human cervical cancer.
    Espinosa M; Cantú D; Herrera N; Lopez CM; De la Garza JG; Maldonado V; Melendez-Zajgla J
    BMC Cancer; 2006 Feb; 6():45. PubMed ID: 16504151
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Expression of Smac/DIABLO is a novel prognostic marker in lung cancer.
    Sekimura A; Konishi A; Mizuno K; Kobayashi Y; Sasaki H; Yano M; Fukai I; Fujii Y
    Oncol Rep; 2004 Apr; 11(4):797-802. PubMed ID: 15010875
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy.
    Yang L; Cao Z; Yan H; Wood WC
    Cancer Res; 2003 Oct; 63(20):6815-24. PubMed ID: 14583479
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tumors acquire inhibitor of apoptosis protein (IAP)-mediated apoptosis resistance through altered specificity of cytosolic proteolysis.
    Hong X; Lei L; Glas R
    J Exp Med; 2003 Jun; 197(12):1731-43. PubMed ID: 12810691
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Direct interaction between survivin and Smac/DIABLO is essential for the anti-apoptotic activity of survivin during taxol-induced apoptosis.
    Song Z; Yao X; Wu M
    J Biol Chem; 2003 Jun; 278(25):23130-40. PubMed ID: 12660240
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Predominant suppression of apoptosome by inhibitor of apoptosis protein in non-small cell lung cancer H460 cells: therapeutic effect of a novel polyarginine-conjugated Smac peptide.
    Yang L; Mashima T; Sato S; Mochizuki M; Sakamoto H; Yamori T; Oh-Hara T; Tsuruo T
    Cancer Res; 2003 Feb; 63(4):831-7. PubMed ID: 12591734
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Peptides targeting caspase inhibitors.
    Tamm I; Trepel M; Cardó-Vila M; Sun Y; Welsh K; Cabezas E; Swatterthwait A; Arap W; Reed JC; Pasqualini R
    J Biol Chem; 2003 Apr; 278(16):14401-5. PubMed ID: 12538646
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapy.
    Kim R; Tanabe K; Uchida Y; Emi M; Inoue H; Toge T
    Cancer Chemother Pharmacol; 2002 Nov; 50(5):343-52. PubMed ID: 12439591
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthetic Smac/DIABLO peptides enhance the effects of chemotherapeutic agents by binding XIAP and cIAP1 in situ.
    Arnt CR; Chiorean MV; Heldebrant MP; Gores GJ; Kaufmann SH
    J Biol Chem; 2002 Nov; 277(46):44236-43. PubMed ID: 12218061
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tissue distribution of Diablo/Smac revealed by monoclonal antibodies.
    Tikoo A; O'Reilly L; Day CL; Verhagen AM; Pakusch M; Vaux DL
    Cell Death Differ; 2002 Jul; 9(7):710-6. PubMed ID: 12058276
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Generation and characterization of Smac/DIABLO-deficient mice.
    Okada H; Suh WK; Jin J; Woo M; Du C; Elia A; Duncan GS; Wakeham A; Itie A; Lowe SW; Wang X; Mak TW
    Mol Cell Biol; 2002 May; 22(10):3509-17. PubMed ID: 11971981
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.